Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
None listed
Sponsors
Dr Shahinur Islam
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of Either sex of age group between 30 to 70 years 2.T1DM with T2DM with peripheral neuropathy,both newly diagnosed and treated patients. 3.patients with controlled blood sugar fir a period of more than 1 year 4.patiens willing to give informed consent and able to participate for 12 weeks
Exclusion criteria
Exclusion criteria: 1. Patients with other metabolic and endocrine disease 2.Patiens with autonomic, proximal and focal neuropathic 3.Neuropathy due to unknown cause or cause other than Diabetes 4.Patiens with wound/Ulcer or other infections 5.Patients with other acute or chronic complications of Diabetes like nephropathy, gangrene etc 6.Alcoholic or drug abusers 7.Pregnant or Lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To asses the effectiveness of HARISANKAR RAS in the management of Madhumeha with special reference to Diabetic NeuropathyTimepoint: 30 days, 60days,90days | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome TimePoints To compare the effect of HARISANKAR RAS and Tab Methylcobalamine(500mg)+Gabapentin(300mg) on Diabetic Neuropathy parameter. Timepoint: 30,60 and 90 days | — |
Countries
India
Contacts
Public ContactDr Manir Uddin Dewan
Govt Ayurvedic College and Hospital Guwahati
Outcome results
None listed